A detailed history of Howard Capital Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Howard Capital Management Inc. holds 4,512 shares of ABBV stock, worth $919,861. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,512
Previous 1,899 137.6%
Holding current value
$919,861
Previous $345,000 124.06%
% of portfolio
0.09%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $404,466 - $472,325
2,613 Added 137.6%
4,512 $773,000
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $303,498 - $345,807
1,899 New
1,899 $345,000
Q1 2018

May 24, 2018

SELL
$92.01 - $123.21 $7.98 Million - $10.7 Million
-86,762 Closed
0 $0
Q4 2017

May 23, 2018

BUY
$89.56 - $98.21 $7.77 Million - $8.52 Million
86,762
86,762 $8.39 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Howard Capital Management Inc. Portfolio

Follow Howard Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howard Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Howard Capital Management Inc. with notifications on news.